Interestingly, activation of CD11b/CD18 with a CD11b agonist LA1 is able to overcome the effects of CD11b/CD18 malfunction in the carriers of the SLE-associated polymorphisms (95). The gene discussed is ITGB2; the disease is systemic lupus erythematosus.